Idexx Laboratories (IDXX) Ratios
Idexx Laboratories Ratios
MX:IDXX's free cash flow for Q2 2026 was $322.52M. For the 2026 fiscal year, MX:IDXX's free cash flow was decreased by $-24.65M and operating cash flow was $347.16M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 1.17 | 1.31 | 1.57 | 0.89 | 1.25 |
| Quick Ratio | 0.84 | 0.95 | 1.17 | 0.59 | 0.90 |
| Cash Ratio | 0.16 | 0.27 | 0.48 | 0.09 | 0.19 |
| Solvency Ratio | 0.69 | 0.60 | 0.54 | 0.37 | 0.49 |
| Operating Cash Flow Ratio | 1.03 | 0.87 | 0.95 | 0.44 | 0.99 |
| Short-Term Operating Cash Flow Coverage | 2.36 | 2.22 | 2.79 | 0.83 | 5.09 |
| Net Current Asset Value | $ -405.11M | $ -298.23M | $ -280.14M | $ -1.04B | $ -791.56M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.32 | 0.30 | 0.33 | 0.54 | 0.42 |
| Debt-to-Equity Ratio | 0.67 | 0.62 | 0.72 | 2.41 | 1.49 |
| Debt-to-Capital Ratio | 0.40 | 0.38 | 0.42 | 0.71 | 0.60 |
| Long-Term Debt-to-Capital Ratio | 0.23 | 0.22 | 0.30 | 0.53 | 0.53 |
| Financial Leverage Ratio | 2.09 | 2.06 | 2.20 | 4.51 | 3.53 |
| Debt Service Coverage Ratio | 2.31 | 2.35 | 2.73 | 1.20 | 4.95 |
| Interest Coverage Ratio | 35.54 | 36.16 | 26.39 | 22.55 | 31.27 |
| Debt to Market Cap | 0.02 | 0.03 | 0.02 | 0.04 | 0.02 |
| Interest Debt Per Share | 13.93 | 12.35 | 13.35 | 18.06 | 12.45 |
| Net Debt to EBITDA | 0.60 | 0.55 | 0.50 | 1.34 | 0.85 |
| Profitability Margins | |||||
| Gross Profit Margin | 61.80% | 61.04% | 59.82% | 59.52% | 58.76% |
| EBIT Margin | 31.66% | 29.28% | 30.12% | 26.72% | 29.00% |
| EBITDA Margin | 35.03% | 32.73% | 33.26% | 30.13% | 32.34% |
| Operating Profit Margin | 31.60% | 28.95% | 29.97% | 26.69% | 28.99% |
| Pretax Profit Margin | 30.77% | 28.48% | 28.99% | 25.54% | 28.07% |
| Net Profit Margin | 24.62% | 22.78% | 23.08% | 20.17% | 23.17% |
| Continuous Operations Profit Margin | 24.62% | 22.78% | 23.08% | 20.17% | 23.17% |
| Net Income Per EBT | 80.01% | 80.00% | 79.63% | 78.97% | 82.52% |
| EBT Per EBIT | 97.36% | 98.36% | 96.72% | 95.68% | 96.85% |
| Return on Assets (ROA) | 31.62% | 26.96% | 25.92% | 24.72% | 30.56% |
| Return on Equity (ROE) | 65.99% | 55.65% | 56.92% | 111.56% | 107.95% |
| Return on Capital Employed (ROCE) | 61.76% | 50.70% | 47.53% | 59.48% | 55.69% |
| Return on Invested Capital (ROIC) | 40.27% | 33.87% | 32.93% | 32.48% | 41.75% |
| Return on Tangible Assets | 37.48% | 31.98% | 30.08% | 29.69% | 37.64% |
| Earnings Yield | 1.96% | 2.60% | 1.83% | 1.99% | 1.33% |
| Efficiency Ratios | |||||
| Receivables Turnover | 6.21 | 6.94 | 6.91 | 6.86 | 7.56 |
| Payables Turnover | 14.89 | 13.30 | 13.29 | 12.37 | 11.42 |
| Inventory Turnover | 4.35 | 3.98 | 3.87 | 3.71 | 4.93 |
| Fixed Asset Turnover | 4.94 | 4.70 | 4.48 | 4.38 | 4.64 |
| Asset Turnover | 1.28 | 1.18 | 1.12 | 1.23 | 1.32 |
| Working Capital Turnover Ratio | 16.44 | 8.90 | 17.89 | 116.62 | 9.57 |
| Cash Conversion Cycle | 118.14 | 116.90 | 119.70 | 122.20 | 90.40 |
| Days of Sales Outstanding | 58.79 | 52.57 | 52.79 | 53.21 | 48.31 |
| Days of Inventory Outstanding | 83.86 | 91.79 | 94.36 | 98.50 | 74.06 |
| Days of Payables Outstanding | 24.51 | 27.45 | 27.45 | 29.52 | 31.97 |
| Operating Cycle | 142.65 | 144.35 | 147.16 | 151.71 | 122.37 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 14.71 | 11.27 | 10.91 | 6.49 | 8.87 |
| Free Cash Flow Per Share | 13.15 | 9.68 | 9.30 | 4.71 | 7.46 |
| Dividend Paid and CapEx Coverage Ratio | 9.45 | 7.10 | 6.78 | 3.65 | 6.32 |
| Capital Expenditure Coverage Ratio | 9.45 | 7.10 | 6.78 | 3.65 | 6.32 |
| Operating Cash Flow Coverage Ratio | 1.09 | 0.94 | 0.85 | 0.37 | 0.73 |
| Operating Cash Flow to Sales Ratio | 0.27 | 0.24 | 0.25 | 0.16 | 0.23 |
| Free Cash Flow Yield | 1.94% | 2.34% | 1.68% | 1.16% | 1.13% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 51.37 | 38.39 | 54.56 | 50.24 | 75.32 |
| Price-to-Sales (P/S) Ratio | 12.59 | 8.75 | 12.59 | 10.13 | 17.45 |
| Price-to-Book (P/B) Ratio | 33.75 | 21.37 | 31.06 | 56.04 | 81.31 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 51.44 | 42.72 | 59.65 | 86.55 | 88.21 |
| Price-to-Operating Cash Flow Ratio | 46.00 | 36.70 | 50.86 | 62.83 | 74.25 |
| Price-to-Earnings Growth (PEG) Ratio | 2.31 | 6.51 | 2.16 | -7.08 | 2.68 |
| Enterprise Value Multiple | 36.54 | 27.27 | 38.37 | 34.96 | 54.80 |
| Enterprise Value | 55.08B | 34.79B | 46.72B | 35.47B | 56.99B |
| EV to EBITDA | 36.54 | 27.27 | 38.37 | 34.96 | 54.80 |
| EV to Sales | 12.80 | 8.93 | 12.76 | 10.53 | 17.72 |
| EV to Free Cash Flow | 52.29 | 43.60 | 60.45 | 90.00 | 89.60 |
| EV to Operating Cash Flow | 46.76 | 37.45 | 51.54 | 65.33 | 75.43 |
| Tangible Book Value Per Share | 13.50 | 13.08 | 12.45 | 1.79 | 2.72 |
| Shareholders’ Equity Per Share | 20.04 | 19.34 | 17.87 | 7.28 | 8.10 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.20 | 0.20 | 0.20 | 0.21 | 0.17 |
| Revenue Per Share | 53.73 | 47.26 | 44.07 | 40.27 | 37.74 |
| Net Income Per Share | 13.23 | 10.77 | 10.17 | 8.12 | 8.74 |
| Tax Burden | 0.80 | 0.80 | 0.80 | 0.79 | 0.83 |
| Interest Burden | 0.97 | 0.97 | 0.96 | 0.96 | 0.97 |
| Research & Development to Revenue | 0.06 | 0.06 | 0.05 | 0.08 | 0.05 |
| SG&A to Revenue | 0.24 | 0.26 | 0.09 | 0.10 | 0.10 |
| Stock-Based Compensation to Revenue | 0.00 | 0.02 | 0.02 | 0.01 | 0.01 |
| Income Quality | 1.11 | 1.05 | 1.07 | 0.80 | 1.01 |
Currency in USD
